PharmaShots | Incisive News in 3 Shots

Subscribe Now

Sol-Gel Technologies

Sol-Gel Technologies and Beimei Pharma Collaborate to Commercialize Twyneo for Treating Acne Vulgaris

Sol-Gel Technologies and Beimei Pharma Collaborate to Commercialize Twyneo for Treating Acne Vulgaris

May 17, 2024

Insights+: The US FDA New Drug Approvals in April 2022

Insights+: The US FDA New Drug Approvals in April 2022

May 19, 2022

Sol-Gel Technologies and Galderma’ Epsolay Receive the US FDA’s Approval for the Treatment of Inflammatory Lesions of Rosacea in Adults

Sol-Gel Technologies and Galderma’ Epsolay Receive the US FDA’s Approval for the Treatment of Inflammatory Lesions of Rosacea in A...

April 25, 2022

Insights+: The US FDA New Drug Approvals in July 2021

Insights+: The US FDA New Drug Approvals in July 2021

August 19, 2021

Sol-Gel Technologies' Twyneo (tretinoin/benzoyl peroxide) Cream Receives the US FDA's Approval for the Treatment of Acne Vulgaris

Sol-Gel Technologies' Twyneo (tretinoin/benzoyl peroxide) Cream Receives the US FDA's Approval for the Treatment of Acne Vulgaris

July 27, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us